Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 14;19:810. doi: 10.1186/s12885-019-5998-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Levels of GPR64 in human endometrial cancer. a Representative immunohistochemistry andsemiquantitative analysis for GPR64 expression in control endometrium from women in proliferative, early, and mid-secretory phases. b Representative immunohistochemistry and semiquantitative analysis for GPR64 expression in endometrial cancer tissues. The semiquantitative analysis of immunohistochemistry analysis was calculated by H-score among 24 control endometrium and 21 endometrial cancer tissues. High level of GPR64 was observed in 100% control endometrium (6/6) and 52.38% endometrial cancer (11/21), and low level was observed in 47.62% endometrial cancer (10/21). ***, p < 0.001